Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
07 October 2024 | Story Anthony Mthembu | Photo Stephen Collett
Global Social Innovation Indaba
Panel discussion during the 2024 Global Social Innovation Indaba held at the University of the Free State, Bloemfontein Campus.

Insightful, thought-provoking and inspiring: These were some of the words used to describe the 2024 Global Social Innovation Indaba, which took place at the Centenary Complex on the University of the Free State’s (UFS’s) Bloemfontein Campus from 30 September to 2 October 2024.

The three-day conference was hosted by the global Social Innovation Exchange (SIX) in collaboration with the UFS, under the theme ‘People Powered Change’. The conference brought together leaders and innovators from South Africa and several other countries, including Louise Pulford, CEO of SIX; Markus Lux, Senior Vice-President at Robert Bosch Stiftung, and Desmond D’Sa from the South Durban Community Environment Alliance (SDCEA), among others.

In her opening address, Acting UFS Vice-Chancellor and Principal Prof Anthea Rhoda welcomed the guests and described the conference as an opportunity to “deliberate, debate, and dissect ideas around the all-important topic of harnessing people-powered change in order to build successful societies”.

Powering social change

As part of the conference guests engaged in a series of panel discussions and activities, and attended presentations on various topics.

D’Sa was one of the first speakers, delivering a keynote address titled ‘An activist guide to people-powered change’. He referred to moments throughout his career in which he has actively worked towards change in his community and beyond, and highlighted some of the work the SDCEA continues to do. Guests were also treated to a spoken word performance by Napo Masheane, Artistic Director at the Performing Arts Centre of the Free State (PACOFS).

Advocate Tembeka Ngcukaitobi touched on several points in his talk, such as what the law meant or means to indigenous people. He explored this by referring back to the colonialist era. Ngcukaitobi, who described law as the most ubiquitous and most stable concept that European settlers brought, indicated that it was brought in two faces: the face of justice, and the face of violence. Therefore, he said, “… the future of law that has been most enduring is the ability of the law to transform itself from violence to justice.”

Guests said they regarded the presentations and dialogues as insightful, and also highlighted their appreciation for being able to interact with the campus itself. This sentiment in large part stemmed from the attendees being split into smaller groups and taken to see different parts of the campus. They also got to see an exhibition exploring the role of art in social justice at the Department of Fine Arts.

Lessons from the conference

The last day featured a panel discussion titled ‘Challenging power dynamics and redefining global exchange’, which included an engagement session with the audience. Guests were able to reflect on the information they had acquired at the conference and challenged themselves to continue working towards change and innovation.

“What I learnt from these three days is that since we all want to do the right thing, we all know what the job that needs to be done is,” said Michael Ngigi, CEO of Thinkplace Africa. “As such, we need to be bold in going for that, and really push back on the status quo that is formed by the places we represent.”

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept